tDCS and Inhibitory Control in PTSD
Evaluating the Impact of Transcranial Direct Current Stimulation on Inhibitory Control in PTSD
1 other identifier
interventional
38
1 country
1
Brief Summary
Large samples (\~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult female participants who report a history of IPV and probable PTSD to participate in a one-day lab study. After completing an IRB-approved informed consent, participants will complete a brief psychiatric diagnostic interview and a battery of questionnaires. They will then complete three blocks of the Stop Signal Task (SST). Participants will be randomized (double-blind, stratified by PTSD diagnosis and psychotropic medication use) to receive 15-min of active or sham multifocal tDCS targeting the rIFG. tDCS will be delivered offline for 11.5-mins after block 1 of the SST and online for 3.5-mins during block 2 of the SST. Sham stimulation will be identical to active tDCS, but electrical current will only be ramped in/out at the beginning and end of the 15-mins. The third block of the SST will be completed after tDCS. Lastly, participants will complete a pictorial trauma-related symptom provocation task. Participants will be compensated with course credit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2023
CompletedFirst Posted
Study publicly available on registry
October 25, 2023
CompletedStudy Start
First participant enrolled
October 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 4, 2024
CompletedJanuary 16, 2025
January 1, 2025
1.1 years
October 4, 2023
January 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Stop Signal Reaction Time (SSRT)
SSRT is a measure of inhibitory control that is calculated by subtracting the mean stop signal delay on "stop" trials from the mean response time on "go" trials
Day 1
Skin conductance level (SCL)
SCL will be measured by collecting electrodermal activity (EDA) on the left hand. Mean SCL during trauma related images will be utilized as a measure of emotional reactivity to trauma-related images.
Day 1
Heart Rate (HR)
HR will be measured using a photophylesmograph on the left hand. Mean HR during trauma related images will be utilized as a measure of emotional reactivity to trauma-related images.
Day 1
Study Arms (2)
Active tDCS
ACTIVE COMPARATORCurrent will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period and a constant current will be delivered for the 15-minutes between ramping
Shame tDCS
SHAM COMPARATORCurrent will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period during which no stimulation will be delivered.
Interventions
Subjects will receive 20 minutes of multifocal transcranial direct current stimulation. The anode will be placed over the frontal pole (FC6, 10-10 EEG) and will be surrounded by 5 return electrodes (cathodes). Current will be set at 1.5mA and will be ramped in/ out at the beginning and end of the 15-minutes of stimulation over the course of 15 seconds.
Eligibility Criteria
You may qualify if:
- Ability to provide informed consent
- Ability and willingness to perform procedures
- Age 18-55
- Female sex
- Meet diagnostic criteria for past-month probable IPV-related PTSD.
- Medication free or stable (≥4 weeks) medication(s)
You may not qualify if:
- Unstable medical, psychiatric, or neurological condition that may necessitate urgent treatment
- Contraindications for tDCS
- History of psychosis, mania, major neurological disorder, significant head trauma, or epilepsy.
- Daily use of psychostimulant medication
- Daily use of medications that significantly lower seizure threshold
- Current suicidal intent
- History of seizures
- Current pregnancy
- Moderate severity substance-use disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gopalkumar Rakesh, PhD
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Randomization (stratified by PTSD status and medication use) into active or shame tDCS. Double blind software will be used to ensure that the experimenter and the subject remain blind during task administration.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 4, 2023
First Posted
October 25, 2023
Study Start
October 27, 2023
Primary Completion
December 4, 2024
Study Completion
December 4, 2024
Last Updated
January 16, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- May 2025 for 9 years.
- Access Criteria
- * Must be a doctoral-level researcher. * Must request documents from the PI or Co-I of the study.
Upon data de-identification, data will be available upon request after study publication. Upon request, other supporting documents (e.g., study protocol and analytic code) will also be available